Form 4: Charles River Laboratories CEO James C. Foster Reports Stock Transaction

James C. Foster, Chairman, President, and CEO of Charles River Laboratories, reports a transaction involving company stock on August 12, 2024.

Summary

• On August 12, 2024, James C. Foster, the Chairman, President, and CEO of Charles River Laboratories International, Inc., reported a transaction involving the company's common stock.
• The transaction involved the disposition of 2,500 shares of common stock at a price of $0.
• Following the reported transaction, Foster directly owns 185,751 shares of common stock.
• Foster also indirectly owns shares through various trusts and a GRAT (Grantor Retained Annuity Trust), including 7,580 shares through a 2022 GRAT, 9,793 shares through a 2023 GRAT, and 20,000 shares through a 2024 GRAT.
• Additionally, Foster indirectly owns 230, 750, and 2,250 shares by Trust, and 10,000 shares held by his spouse.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing. The sentiment is neither positive nor negative as it simply reports a transaction.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key executives and their potential impact on the company's stock.

Stakeholder Impact

• The transaction may be of interest to shareholders as it provides insight into the actions of a key executive.

Key Dates